A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

ELISpot Assay for Quantifying Antigen-Specific and Total Antibody-Secreting Cells in Blood and Bone Marrow of Immunized Rhesus Macaques

142 views

⸱

DOI:

10.3791/71836

⸱

August 21st, 2026

 ,  ,  ,  ,  ,  , 

In This Article

Summary

B-Cell ELISpot is a validated method for quantifying the magnitude and durability of antigen-specific IgG, IgM, and IgA long-lived plasma cells, as well as total antibody-secreting cells (ASCs), in both blood (reflecting short-lived plasmablasts following immunization) and more durable bone marrow ASCs.

Abstract

Evaluation of novel vaccine antigens and adjuvants traditionally relies on measuring antibody titers, which require time to develop following immunization. Quantification of antibody-secreting cells (ASCs) after primary and booster immunizations provides an earlier, mechanistically informative measure of vaccine-induced humoral immunity and can facilitate the optimization of vaccine formulations and immunization strategies. Here, a protocol for enumerating ASCs from peripheral blood mononuclear cells (PBMCs) and bone marrow (BM) cells of rhesus macaques is described; rhesus macaques are an important preclinical model for HIV vaccine research. This enzyme-linked immunospot (ELISpot) assay enables the quantification of both antigen-specific and total IgG, IgM, and IgA ASCs by measuring their absolute and relative frequencies. In peripheral blood, the assay captures the peak plasmablast response following immunization, whereas in bone marrow it detects the accumulation of antigen-specific plasma cells of different isotypes, thereby assessing the durability of long-lived ASCs. This protocol offers a robust and reproducible approach for evaluating immunogen and adjuvant combinations in preclinical vaccine studies and provides valuable data to support the translation of promising vaccine candidates into clinical development.

Introduction

Antibody-secreting cells (ASCs) are key components of adaptive immunity and include both short-lived plasmablasts, which are generated rapidly following immunization, and long-lived plasma cells, which are responsible for sustained antibody production. Plasmablasts are transiently detectable in peripheral blood and secondary lymphoid organs, reaching peak frequencies at defined time points following immunization that vary according to the vaccine formulation and host species (typically days 4–5 in rhesus macaques and approximately day 7 in humans). In contrast, mature plasma cells are long-lived and primarily reside within secondary lymphoid tissues and the bone....

Access restricted. Please log in or start a trial to view this content.

Protocol

The rhesus macaques used in this protocol were sourced from the specific pathogen-free (SPF) colonies of the New Iberia Research Center and housed at the Michale E. Keeling Center for Comparative Medicine and Research, the University of Texas MD Anderson Cancer Center. Animal care and all experimental procedures complied with the Guide for the Care and Use of Laboratory Animals and were approved by the University of Texas MD Anderson Cancer Center Institutional Animal Care and Use Committee (Protocol #2616RN00).

This protocol represents an optimization of the technique described in previous immunization pre-clinical studies

Access restricted. Please log in or start a trial to view this content.

Results

In this B-cell ELISpot assay, antibody-secreting cells (ASCs) were detected using CH505 SOSIP, a soluble HIV-1 envelope glycoprotein (Env) trimer, as the coating antigen in a vaccine study aimed at eliciting broadly neutralizing antibodies (bnAbs) against HIV-1. Figure 1 illustrates the ELISpot plate layout used to quantify total and antigen-specific ASCs on separate plates. The layout identifies individual animals and the well positions assigned for IgG, IgM, and IgA analyses. Plate labels .......

Access restricted. Please log in or start a trial to view this content.

Discussion

B-cell ELISpot is a sensitive method for detecting total immunoglobulin and antigen-specific antibody-secreting cell (ASC) responses in blood, plasma, and bone marrow cells8,9,10,11. Several steps are critical to ensuring the protocol's reproducibility. First, membranes should be precisely coated with the optimal concentration of the capture antibody. Membrane blocking is essential to preve.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no financial interest to declare.

Acknowledgements

The authors would like to thank the animals and the research care staff at the Keeling Center for Comparative Medicine and Research for their care, and many former team members and collaborators for successive improvements to the procedure. Funding for this NHP HIV vaccine project was provided by NIH awards 5R01AI183472 to MBZ and R24OD010947 to FJV.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
ACK LysisQuality Biological118-156-101500 ml
70µm strainerFisher22363548Sterile cell strainer, fit for 50 mL conical tubes
AEC working SubstrateBD Biosciences551951Reagents for 10 plate(s)
Analysis: ExcelMicrosoft officeVersion 2508 Build 16.0.19127.20678Microsoft Excel for Microsoft 365
Analysis: GraphPad PrismGraphPad Software, LLCVersion 10.6.1 (892) GraphPad Prism 10
Anti Rhesus IgA biotinNHPRRAB-3086851lyophilized
Anti-monkey IgG biotinRocklandP/N 617-106-012lyophilized
Anti-monkey IgM biotinRocklandP/N 617-106-007lyophilized
Blocking mediaLab prepared reagentsformulated in-houseRPMI-10
Buffer for diluting the secondary antibody and HRPLab prepared reagentsformulated in-house1X DPBS with 1%FBS
Centrifuge Thermo Scientific75004521Sorvall Legend XTR, Make: 2013, TX-750 rotor and 75003608 (Round bucket)
Coating bufferLab prepared reagentsformulated in-house1X DPBS
DPBSGibco14190-1361X
ELISpot platesMillipore SigmaMSHAN4B5050 plates pack
Fetal Bovine Serum (FBS)Omega ScientificFB-011X
FicollSTEMCELL Technologies18061500 ml
GNL UnconjugatedVector LaboratoriesL-1240-5lyophilized
Horseradish Peroxidase (HRP) - AvidinVector LaboratoriesA-20045mg/ml ready to use
Mabtech IRIS Fluorospot/ELISpot readerMabtech ABP/N: 2000Automated imaging and analysis for ELISpot and Flurospot assay
Penicillin/StreptomycinGibco15140-122100X
Plate washerBioTek Instruments, Inc.REF# 405TSRS405 TS Microplate washer
RPMI-10Lab prepared reagentsformulated in-houseRPMI-1640 + 10% Fetal Bovine Serum and 1% Penicillin/Streptomycin 
RPMI-1640Gibco22400-0711X
Tween20Sigma Life sciencesP7949500ml
Unconjugated Polyclonal Goat anti monkey IgG+IgA+IgM Antibody IgG/IgM/IgALS-BioC347340lyophilized
Wash buffer (Antigen Specific Plates)Lab prepared reagentsformulated in-house(DPBS 1X only)
Wash buffer (Total Ig Plates)Lab prepared reagentsformulated in-house( DPBS 1X + 0.05% Tween 20)

References

  1. Hwai H, Chen YY, Tzeng SJ. B-Cell ELISpot Assay to Quantify Antigen-Specific Antibody-Secreting Cells in Human Peripheral Blood Mononuclear Cells. Methods Mol Biol. 2018;1808:133-141.
  2. Haralambieva IH, Ovsyannikova IG, Kennedy RB, Poland GA. Detection and Quantification of Influenza A/H1N1 Virus-Specific Memory B Cells in Human PBMCs Using ELISpot Assay. Methods Mol Biol. 2018;1808:221-236.
  3. Sahay B, Aranyos AM, McAvoy A, Yamamoto JK. Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine. Methods Mol Biol. 2018;1808:197-219.
  4. Silveira EL, et al. Vaccine-induced plasmablast responses in rhesus macaques: Phenotypic c....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Peripheral BloodVaccine ImmunogenicityPlasmablast ResponsePlasma CellsImmunization StrategyPreclinical Vaccine Model

This article has been published

Video Coming Soon